Open access
188
Views
12
CrossRef citations to date
0
Altmetric
Original Research
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
Myrlene S Aigbogun1 Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA, [email protected]Correspondence[email protected]
, Sizhu Liu2 Global Health Economics and Outcomes Research, Xcenda, Palm Harbor, FL, USA
, Siddhesh A Kamat1 Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA, [email protected]
, Christophe Sapin3 Global Analytics, Lundbeck, Paris, France
, Amy M Duhig2 Global Health Economics and Outcomes Research, Xcenda, Palm Harbor, FL, USA
& Leslie Citrome4 Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA
Pages 443-456
|
Published online: 16 Aug 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.